Cargando…

Thrombotic Processes in Multiple Sclerosis as Manifestation of Innate Immune Activation

Detalles Bibliográficos
Autor principal:	Koudriavtseva, Tatiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083343/ https://www.ncbi.nlm.nih.gov/pubmed/25071707 http://dx.doi.org/10.3389/fneur.2014.00119

Ejemplares similares

Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Concurrence of Multiple Sclerosis and Brain Tumors
por: Plantone, Domenico, et al.
Publicado: (2015)

Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Demyelinating and Thrombotic Diseases of the Central Nervous System: Common Pathogenic and Triggering Factors
por: Koudriavtseva, Tatiana, et al.
Publicado: (2015)

Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review
por: Stefanile, Annunziata, et al.
Publicado: (2022)

Commentary: Acute Hemorrhagic Leukoencephalitis (Weston–Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana
Publicado: (2016)

A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Innate Immune Cells: Monocytes, Monocyte-Derived Macrophages and Microglia as Therapeutic Targets for Alzheimer’s Disease and Multiple Sclerosis
por: Fani Maleki, Adham, et al.
Publicado: (2019)

Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016)

Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

TLR2 – an innate immune checkpoint in multiple sclerosis
por: Hossain, Md Jakir, et al.
Publicado: (2015)

Innate immune activation as cofactor in pemphigus disease manifestation
por: Eichkorn, Ramona A., et al.
Publicado: (2022)

Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
por: Barry, Alison, et al.
Publicado: (2016)

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis—A Longitudinal Observational Study
por: Riepl, Ester, et al.
Publicado: (2018)

Fibrinogen Deficiency with Thrombotic Manifestations
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2022)

Innate immunity in systemic sclerosis
por: O’Reilly, S.
Publicado: (2020)

Paroxysmal Symptoms As the First Manifestation of Multiple Sclerosis Mimicking a Transient Ischemic Attack: A Report of Two Cases
por: Zhang, Yao, et al.
Publicado: (2017)

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2020)

Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis
por: Piec, Pierre-Alexandre, et al.
Publicado: (2021)

Gut Microbes Regulate Innate Immunity and Epilepsy
por: Zhang, Linhai, et al.
Publicado: (2022)

Subcortico-amygdala pathway processes innate and learned threats
por: Khalil, Valentina, et al.
Publicado: (2023)

Activation of endogenous neural stem cells for multiple sclerosis therapy
por: Michailidou, Iliana, et al.
Publicado: (2015)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity—Report of a Case and Review of the Literature
por: Zimmermann, Julian, et al.
Publicado: (2017)

Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
por: Ahmed, Md. Mahiuddin, et al.
Publicado: (2021)

Cytopathic effects: virus-modulated manifestations of innate immunity?
por: Agol, Vadim I.
Publicado: (2012)

Cognitive Dysfunction in Multiple Sclerosis
por: Guimarães, Joana, et al.
Publicado: (2012)

Editorial: Fatigue in Multiple Sclerosis
por: Dettmers, Christian, et al.
Publicado: (2015)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Cerebellar Dysfunction in Multiple Sclerosis
por: Wilkins, Alastair
Publicado: (2017)

Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis
por: Bianchi, Alessia, et al.
Publicado: (2023)

Leucine Rich Repeat Kinase 2 and Innate Immunity
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2020)

Models of Innate Neural Attractors and Their Applications for Neural Information Processing
por: Solovyeva, Ksenia P., et al.
Publicado: (2016)

Can Enhancing Neuronal Activity Improve Myelin Repair in Multiple Sclerosis?
por: Maas, Dorien A., et al.
Publicado: (2021)

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells
por: Gresle, Melissa M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dguahndc21jl1c5surqkuo0ent